| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
NEW APPROACHES TO THE TREATMENT OF HEPATIC MALIGNANCIES |
From the Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Correspondence: Address correspondence and reprint requests to: Martin Fuss, MD, Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78229; Fax: 210-949-5085; E-mail: fuss{at}uthscsa.edu
ABSTRACT
Only a subset of patients with primary and secondary liver tumors are eligible for surgical resection because of either the presence of extrahepatic disease, increased number of hepatic lesions, the anatomical distribution of tumors within the liver, and/or general medical inoperability. Nonsurgical, ablative tumor treatment may benefit selected patients by preserving normal liver function. This review presents the concept and technology of stereotactic body radiation therapy and summarizes available clinical data describing applications in the treatment of malignant liver tumors. We present predominantly peer-reviewed data but also summarize recent clinical developments along with discussions of current ongoing and planned multicenter studies.
Key Words: Key Words: Stereotactic body radiation therapy Review Liver ablation Liver metastasis Hepatocellular carcinoma
This article has been cited by other articles:
![]() |
R. D. Timmerman, C. S. Bizekis, H. I. Pass, Y. Fong, D. E. Dupuy, L. A. Dawson, and D. Lu Local Surgical, Ablative, and Radiation Treatment of Metastases CA Cancer J Clin, May 1, 2009; 59(3): 145 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Dawson Radiation Therapy for Liver Metastases ASCO Educational Book, January 1, 2008; 2008(1): 161 - 164. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |